NUGT Gold Miners Bull 3X Direxion gains 23% Jul 13, 2020

http://www.priceseries.com/trade/NUGT-Gold-Miners-Bull-3X-Direxion-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2020061920200713.html

ETSY Etsy, Inc. gains 34% Jul 13, 2020

Etsy, Inc. operates as a commerce platform to make, sell, and buy goods online and offline worldwide. Its platform includes its markets, services, and technology, which enables to engage a community of sellers and buyers. The company offers approximately 45 million items across approximately 50 retail categories to buyers. It also provides various seller services, including direct checkouts, promoted listings, and shipping labels, as well as Pattern by Etsy to create custom Websites; and seller tool and education resources to start, manage, and scale businesses to entrepreneurs primarily through Etsy.com. In addition, the company operates A Little Market, a handmade and supplies market for sellers and buyers. Etsy, Inc. was founded in 2005 and is headquartered in Brooklyn, New York.http://www.priceseries.com/trade/ETSY-Etsy-Inc-stock-gains-34-percent-a-Trade-Record-by-priceSeries-2020061220200713.html

DRNA Dicerna Pharmaceuticals, Inc. gains 16% Jul 10, 2020

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company's development programs include DCR-PH1 for the treatment of primary hyperoxaluria type 1 (PH1) through targeting the gene encoding the liver enzyme glycolate oxidase; and other rare inherited diseases involving genes expressed in the liver. It is also developing DCR-MYC, which is in Phase I clinical study for the treatment of various cancers in patients with solid tumors, multiple myeloma, or lymphoma, as well as in Phase Ib/II clinical trial to treat cancer in patients with advanced hepatocellular carcinoma. In addition, the company is developing KRAS oncogene, a gene that is mutated in various cancers, including non-small cell lung cancer, colorectal cancer, and pancreatic cancer; and a therapeutic targeting a second cancer-related gene. It has a research collaboration and license agreement with Kyowa Hakko Kirin Co., Ltd. for the research, development, and commercialization of Dicer substrate short interfering RNAs (DsiRNA) molecules and drug delivery technologies for therapeutic targets in oncology; license agreement with City of Hope, an academic research and medical center to manufacture, use, offer for sale, sell, and import products related to DsiRNA for the prevention and treatment of various diseases in humans; and license agreement with Plant Bioscience Limited to research, discover, develop, manufacture, sell, import, and export products incorporating short RNA molecules. Dicerna Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Cambridge, Massachusetts.http://www.priceseries.com/trade/DRNA-Dicerna-Pharmaceuticals-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2020061520200710.html

CPST Capstone Turbine Corp. gains 21% Jul 13, 2020

Capstone Turbine Corporation develops, manufactures, markets, and services microturbine technology solutions for use in stationary distributed power generation applications worldwide. It offers microturbine units, subassemblies, components, and various accessories for applications, including cogeneration comprising combined heat and power (CHP) and integrated CHP, as well as combined cooling, heat, and power; and renewable energy, natural resources, and critical power supply. The company's microturbines are also used as battery charging generators for hybrid electric vehicle applications. It also provides various accessories, including rotary gas compressors with digital controls; heat recovery modules for CHP applications; dual mode controllers that allow automatic transition between grid connect and stand-alone modes; batteries with digital controls for stand-alone/dual-mode operations; batteries with digital controls; power servers for multipacked installations; protocol converters for Internet access; packaging options; and miscellaneous parts, such as frames, exhaust ducting, and installation hardware. In addition, the company remanufactures microturbine engines; and provides after-market parts and services, as well as repair and maintenance services. It markets and sells its products primarily through distributors and original equipment manufacturers. Capstone Turbine Corporation was founded in 1988 and is headquartered in Chatsworth, California.http://www.priceseries.com/trade/CPST-Capstone-Turbine-Corp-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2020062920200713.html

COUP Quotient Technology Inc gains 28% Jul 13, 2020

N/Ahttp://www.priceseries.com/trade/COUP-Quotient-Technology-Inc-stock-gains-28-percent-a-Trade-Record-by-priceSeries-2020061220200713.html

ALRM Alarm.com Holdings, Inc. gains 34% Jul 13, 2020

Alarm.com Holdings, Inc. provides cloud-based software platform solutions for the smart homes and businesses in the United States and internationally. The company provides interactive security solutions to control and monitor their security systems, as well as connected security devices, including door locks, garage doors, and video cameras; and high definition video monitoring solutions, such as live streaming, smart clip capture, secure cloud storage, video alerts, continuous HD recording, and commercial video surveillance solutions. It also offers intelligent automation and energy management solutions, including smart thermostat schedules, responsive savings, precision comfort, geo-services, demand response programs, and energy usage and environmental monitoring solutions. In addition, the company provides service provider solutions, including a permission-based online portal that offers account management, sales, marketing, training, and support tools; installation and support tools; business management services; and sales, marketing, and training services. It serves residential and business subscribers. Alarm.com Holdings, Inc. was founded in 2000 and is headquartered in Tysons, Virginia.http://www.priceseries.com/trade/ALRM-Alarmcom-Holdings-Inc-stock-gains-34-percent-a-Trade-Record-by-priceSeries-2020060120200713.html

ALNY Alnylam Pharmaceuticals, Inc. gains 17% Jul 13, 2020

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference. Its pipeline of investigational RNAi therapeutics is focused on genetic medicines, cardio-metabolic diseases, and hepatic infectious diseases. The company's clinical development programs include Patisiran, which is in Phase III clinical trial for the treatment of transthyretin-mediated amyloidosis (ATTR); Fitusiran, an investigational RNAi therapeutic that is in Phase I/II clinical trial for the treatment of hemophilia and rare bleeding disorders; and Inclisiran (ALN-PCSsc), which is in Phase II clinical trial for hypercholesterolemia. Its early stage clinical programs include Givosiran that is in Phase I trial to treat acute hepatic porphyrias; ALN-CC5 for the treatment of complement-mediated diseases; ALN-GO1 to treat primary hyperoxaluria 1; ALN-TTRsc02, an investigational RNAi therapeutic targeting TTR for the treatment of various forms of ATTR amyloidosis; and ALN-HBV for the treatment of Hepatitis B virus. The company has strategic alliances and collaboration agreements primarily with Sanofi Genzyme; The Medicines Company; Monsanto Company; Takeda Pharmaceutical Company Limited; Ionis Pharmaceuticals, Inc.; The University of British Columbia; and Acuitas Therapeutics Inc.; and Arbutus Biopharma Corporation. Alnylam Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Cambridge, Massachusetts.http://www.priceseries.com/trade/ALNY-Alnylam-Pharmaceuticals-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2020061620200713.html

TROV TrovaGene, Inc. gains 48% Jul 2, 2020

Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary molecular genetic detection technology for use in pharmaceutical development, clinical research, and medical testing in various clinical disciplines in the United States. The company intends to enhance the treatment outcomes for cancer patients through its proprietary technology to detect and quantitatively monitor circulating tumor DNA (ctDNA) using urine or blood samples. It offers Precision Cancer Monitoring (PCM) platform, which provides cancer monitoring by tracking and quantifying levels of ctDNA from either urine or blood samples, as well as intends to offer clinical information beyond the current standard of care. The company also provides assays for the BRAF, KRAS, and epidermal growth factor receptor oncogenes; and engages in developing mutation coverage for other cancers, such as lung and colorectal cancers, as well as targeting clinically validated resistance mutations for gene rearrangements, including ALK, RET, and ROS. In addition, it offers laboratory developed tests for pharmaceutical companies and third party laboratories. The company has a license agreement with Nerviano Medical Sciences to develop and commercialize therapeutic candidate PCM-075. The company was formerly known as Xenomics, Inc. and changed its name to Trovagene, Inc. in January 2010. Trovagene, Inc. was founded in 1999 and is headquartered in San Diego, California.http://www.priceseries.com/trade/TROV-TrovaGene-Inc-stock-gains-48-percent-a-Trade-Record-by-priceSeries-2020061820200702.html

PMTS CPI Card Group Inc. gains 29% Jul 9, 2020

Largest US provider of plastic credit and debit cards.http://www.priceseries.com/trade/PMTS-CPI-Card-Group-Inc-stock-gains-29-percent-a-Trade-Record-by-priceSeries-2020061220200709.html

NMM Navios Maritime Partners LP gains 15% Jul 9, 2020

Navios Maritime Partners L.P. owns and operates container and dry bulk vessels in Asia, Europe, North America, and Australia. The company offers seaborne transportation services for a range of dry cargo commodities, including iron ore, coal, grain, and fertilizers, as well as charters its vessels under medium to long-term charters. Its fleet comprises 12 Panamax vessels, 9 Capesize vessels, 3 Ultra-Handymax vessels, and 7 container vessels. Navios GP L.L.C. serves as the general partner of Navios Maritime Partners L.P. The company was founded in 2007 and is based in Monaco.http://www.priceseries.com/trade/NMM-Navios-Maritime-Partners-LP-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2020061720200709.html